Ethyl 5-amino-2-phenyl-3-sulfanylidene-2,3-dihydro-1,2-thiazole-4-carboxylate, 97%, 100mg

4-Bromo-1-(4-ethylphenyl)-1H-pyrazole, 98%, 1g

1-(6-Ethynylpyridin-2-yl)ethanone, 98%, 1g

N-Cyclopropyl-2-nitro-4-(trifluoromethyl)aniline, 95.0%, 5g

2-(3,5-Difluorophenyl)propan-2-amine hydrochloride, 95.0%, 1g

Cyclothiazide (mixture of isomers)>95.0%(HPLC)25mg

4,6-Dichloro-2-trifluoromethylpyrimidine, 95.0%, 10g

Oxazole, 2,2'-(1-methylethylidene)bis[4,5-dihydro-4,5-diphenyl-, (4R,4'R,5S,5'S)-, 97%, 1g

1-(2-(Trifluoromethyl)phenyl)ethanamine, 95.0%, 1g

N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-3-yl)pyridine-3-carboxamide, 98%, 100mg

2-Ethoxy-5-fluorobenzoic acid, 97.0%, 1g

2-Bromo-4-chloro-3-nitropyridine, 95%, 5g

4-Bromo-4'-iodo-1,1'-biphenyl, 95.0%, 100g